JD Schneider’s practice focuses on complex intellectual property litigation, with an emphasis on high-stakes patent cases. He counsels clients through pre-litigation investigations, discovery, claim construction, dispositive motions, arbitration and trial. A former software engineer, JD leverages his experience designing, developing and testing software to evaluate patents for both infringement and invalidity purposes. He has represented both petitioners and patent owners in PTAB proceedings, and has significant experience with Section 101 invalidity issues.
Prior to joining the firm, JD worked as a patent litigation association with an Am Law 100 law firm. He served as a judicial clerk to Judge Michael Watanabe of the U.S. District Court for the District of Colorado. He earned his J.D. from the University of Denver Sturm College of Law and holds an undergraduate degree in computer science from Colorado State University. Prior to his legal career, JD worked as a software engineer with Sun Microsystems (now Oracle), where he developed system health monitoring and update management applications.
JD is admitted to practice in Colorado and before the United States Patent and Trademark Office. He is not admitted to practice law in California, and his practice is supervised by partners of the firm admitted in California.
Abbott Diabetes Care v. Dexcom
We defended Dexcom in the District of Delaware where Abbott asserted a dozen patents targeting Dexcom’s G6 continuous glucose monitoring technology. The Keker team narrowed the case to four patents prior to trial, including by invalidating an Abbott patent at summary judgment, and excluded Abbott’s expert testimony regarding reasonable royalty damages. Following a two-week trial, the jury invalidated another Abbott patent and found two were not infringed. The Court also declined to let the Jury consider damages on the remaining patent, cementing a defense victory for the Keker trial team.
08/15/2024
The 2025 edition of The Best Lawyers in America® and the Best Lawyers: Ones to Watch® in America featured 25 KVP attorneys. Read more
03/22/2024
Law360 has reported that a Delaware federal jury has cleared Dexcom, represented by Keker, Van Nest & Peters, of infringing two glucose monitor patents owned by an Abbott Laboratories unit, while finding infringement of one that was not willful. It hung on a fourth. The trial was overseen by Third Circuit Judge Kent A. Jordan in the U.S. District of Delaware, who decided a second trial will be held to determine any damages. Read more